RISEDRONATE SOD DR 35 MG TAB

risedronate sodium
$26.2805per EA

Strength

30.1; 4.9 mg/1; mg/1

NDC

59762040704

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA022560

On Market Since

3/2/2018

Pharmacological Classes

Bisphosphonate
Bisphosphonate
Diphosphonates
Diphosphonates

Price History

1W

0.0%

1M

+1.6%

3M

+6.4%

6M

+8.9%

1Y

-1.4%

3Y

-8.3%

5Y

-16.6%

All

-21.2%